# A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies

> **NCT03980821** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 10 (actual)

## Conditions studied

- Advanced Solid Malignancies

## Interventions

- **DRUG:** AZD4635

## Key facts

- **NCT ID:** NCT03980821
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-04
- **Primary completion:** 2020-09-07
- **Final completion:** 2020-09-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980821, "A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03980821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*